Cargando…

Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters

PURPOSE: To evaluate the safety and efficacy of transepithelial accelerated corneal crosslinking (CXL) for advanced keratoconus eyes with maximum keratometry (Kmax) values >58 diopters (D). SETTING: Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China. DESIGN: Pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ling, Zhao, Jing, Zhang, Xiaoyu, Shen, Yang, Tian, Mi, Zhou, Xingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845528/
https://www.ncbi.nlm.nih.gov/pubmed/34288636
http://dx.doi.org/10.1097/j.jcrs.0000000000000733
_version_ 1784651690033545216
author Sun, Ling
Zhao, Jing
Zhang, Xiaoyu
Shen, Yang
Tian, Mi
Zhou, Xingtao
author_facet Sun, Ling
Zhao, Jing
Zhang, Xiaoyu
Shen, Yang
Tian, Mi
Zhou, Xingtao
author_sort Sun, Ling
collection PubMed
description PURPOSE: To evaluate the safety and efficacy of transepithelial accelerated corneal crosslinking (CXL) for advanced keratoconus eyes with maximum keratometry (Kmax) values >58 diopters (D). SETTING: Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China. DESIGN: Prospective parallel control study. METHODS: 41 keratoconus eyes from 41 patients (mean age, 21.93 ± 5.48 years) who underwent transepithelial accelerated CXL were included prospectively. The enrolled eyes were divided into 2 groups according to their Kmax values (Group A, Kmax ≥58.0 D; Group B, Kmax <58.0 D). The examinations including assessment of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography, and corneal endothelial cell density count were conducted preoperatively, at 1 day, 1 month, 3 months, 6 months, and 1 year postoperatively. RESULTS: All 41 eyes finished 1 year follow-up. No statistical difference was noted between the mean UDVA and CDVA in both groups throughout the follow-up duration. At 1-year postoperative follow-up, the CDVA increased by ≥2 lines in 45% (9/20) and 28.6% (6/21) eyes in Groups A and B, respectively. The mean preoperative Kmax in Groups A and B were 62.51 ± 3.34 D and 49.98 ± 4.32 D, respectively, and that at postoperative 1-year follow-up were 61.94 ± 4.11 D and 50.24 ± 4.72 D, respectively. The Kmax values of 30% (6/20) eyes in Group A and 4.8% (1/21) eyes in Group B decreased by more than 1 D. Deduction of flat K, steep K, mean K, and Kmax showed no significant difference between the 2 groups at 1-year postoperative follow-up. Moreover, 20% (4/20) and 23.8% (5/21) of eyes in Groups A and B, respectively, showed progress at postoperative 1-year follow-up. CONCLUSIONS: Transepithelial accelerated CXL can safely treat advanced keratoconus eyes with Kmax values ≥58.0 D with some extent of efficacy and has similar progressive rate as Kmax values <58.0 D.
format Online
Article
Text
id pubmed-8845528
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-88455282022-02-24 Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters Sun, Ling Zhao, Jing Zhang, Xiaoyu Shen, Yang Tian, Mi Zhou, Xingtao J Cataract Refract Surg Articles PURPOSE: To evaluate the safety and efficacy of transepithelial accelerated corneal crosslinking (CXL) for advanced keratoconus eyes with maximum keratometry (Kmax) values >58 diopters (D). SETTING: Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai, China. DESIGN: Prospective parallel control study. METHODS: 41 keratoconus eyes from 41 patients (mean age, 21.93 ± 5.48 years) who underwent transepithelial accelerated CXL were included prospectively. The enrolled eyes were divided into 2 groups according to their Kmax values (Group A, Kmax ≥58.0 D; Group B, Kmax <58.0 D). The examinations including assessment of uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography, and corneal endothelial cell density count were conducted preoperatively, at 1 day, 1 month, 3 months, 6 months, and 1 year postoperatively. RESULTS: All 41 eyes finished 1 year follow-up. No statistical difference was noted between the mean UDVA and CDVA in both groups throughout the follow-up duration. At 1-year postoperative follow-up, the CDVA increased by ≥2 lines in 45% (9/20) and 28.6% (6/21) eyes in Groups A and B, respectively. The mean preoperative Kmax in Groups A and B were 62.51 ± 3.34 D and 49.98 ± 4.32 D, respectively, and that at postoperative 1-year follow-up were 61.94 ± 4.11 D and 50.24 ± 4.72 D, respectively. The Kmax values of 30% (6/20) eyes in Group A and 4.8% (1/21) eyes in Group B decreased by more than 1 D. Deduction of flat K, steep K, mean K, and Kmax showed no significant difference between the 2 groups at 1-year postoperative follow-up. Moreover, 20% (4/20) and 23.8% (5/21) of eyes in Groups A and B, respectively, showed progress at postoperative 1-year follow-up. CONCLUSIONS: Transepithelial accelerated CXL can safely treat advanced keratoconus eyes with Kmax values ≥58.0 D with some extent of efficacy and has similar progressive rate as Kmax values <58.0 D. Wolters Kluwer 2022-02-01 2021-06-23 /pmc/articles/PMC8845528/ /pubmed/34288636 http://dx.doi.org/10.1097/j.jcrs.0000000000000733 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of ASCRS and ESCRS https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Articles
Sun, Ling
Zhao, Jing
Zhang, Xiaoyu
Shen, Yang
Tian, Mi
Zhou, Xingtao
Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
title Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
title_full Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
title_fullStr Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
title_full_unstemmed Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
title_short Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
title_sort transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845528/
https://www.ncbi.nlm.nih.gov/pubmed/34288636
http://dx.doi.org/10.1097/j.jcrs.0000000000000733
work_keys_str_mv AT sunling transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters
AT zhaojing transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters
AT zhangxiaoyu transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters
AT shenyang transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters
AT tianmi transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters
AT zhouxingtao transepithelialacceleratedcornealcrosslinkingforkeratoconuseyeswithmaximumkeratometryvalueslargerthan58diopters